![pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg)
For the most recent fiscal period company increased a shortfall per share of $-1.45 per share compare to $-0.15 a year prior and surged shortfall from $-1.36 per share from the previous quarter.
Revenues grew strongly by 75.117 % to $
1.87 millions from $1.07 millions in the corresponding quarter a year prior and sequentially Revenues surged by 40.646 % from $1.33 millions.
In the most recent fiscal period Pulmatrix Inc reported net shortfall of $-5.052 million, instead of deficit of $-8.184 millions in the corresponding quarter a year ago.
Pulmatrix Inc is expected to report next financial recent numbers on March 28, 2023.